Sterling Investment Advisors, Ltd. United Therapeutics Corp Transaction History

Sterling Investment Advisors, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$78.31 - $95.34 $187,944 - $228,816	-2,400 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$74.85 - $85.99 $54,266 - $62,342	-725 Reduced 23.2%	2,400 $191,000
Q2 2019 Aug 06, 2019	SELL	$76.06 - $120.81 $148,317 - $235,579	-1,950 Reduced 38.42%	3,125 $244,000
Q4 2018 Jan 18, 2019	SELL	$101.4 - $128.73 $88,725 - $112,638	-875 Reduced 14.71%	5,075 $552,000
Q2 2018 Jul 26, 2018	BUY	$101.14 - $118.31 $25,285 - $29,577	250 Added 4.39%	5,950 $673,000
Q1 2018 Apr 23, 2018	BUY	$107.21 - $151.94 $32,162 - $45,582	300 Added 5.56%	5,700 $640,000
Q4 2017 Jan 29, 2018	BUY	$118.58 - $151.28 $148,225 - $189,100	1,250 Added 30.12%	5,400 $799,000
Q2 2017 Aug 09, 2017	BUY	N/A	4,150	4,150 $538,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.